Can Glargine Reduce the Number of Lung Infections in Patients With Cystic Fibrosis-Related Diabetes?

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes care 2005-09, Vol.28 (9), p.2333-2333
Hauptverfasser:	Franzese, Adriana, Spagnuolo, Maria Immacolata, Sepe, Angela, Valerio, Giuliana, Mozzillo, Enza, Raia, Valeria
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Care and treatment Child Complications and side effects Cystic fibrosis Cystic Fibrosis - complications Cystic Fibrosis - genetics Cystic Fibrosis Transmembrane Conductance Regulator - genetics Diabetes Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - etiology Dosage and administration Drug therapy Forced Expiratory Volume Humans Hypoglycemic Agents - therapeutic use Insulin - analogs & derivatives Insulin - therapeutic use Insulin Glargine Insulin, Long-Acting Lung - drug effects Lung - physiopathology Risk factors Sequence Deletion
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!